Pulmonary Tuberculosis and Diabetes
Conditions
Interventions
Experimental group:Wearing CGM
Sponsors
Shenzhen Third People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Male or female age>18 years old; 2. Confirmed drug-susceptible pulmonary tuberculosis through molecular and/or phenotypic drug susceptible test; 3. Confirmed type 2 diabetes according to guideline; 4. Voluntarily participate in this study, agree to wear a continuous glucose monitoring system for a total of 2 months during the strengthening period, and regular follow up until anti-TB treatment completion.
Exclusion criteria
Exclusion criteria: 1. Individuals with severe skin allergies or other conditions who are unable to wear a continuous glucose monitoring system; 2. Drug-resistant tuberculosis patients; 3. Other situations evaluated by the researcher and deemed unsuitable for participation in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The relationship between TIR and sputum negative conversion at the end of 2 months and the treatment outcome of pulmonary tuberculosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of adverse events;Abnormal rates between blood glucose indicators and conventional fingertip blood glucose, venous blood glucose, and HbA1c; | — |
Countries
China
Contacts
Public ContactPeize Zhang
Shenzhen Third People's Hospital
Outcome results
None listed